Headquartered in Baltimore, MD Fiscal year ends December NYSE: MED medifastinc.com
Medifast, Inc. (NYSE: MED) is a metabolic health and wellness company operating through its science-backed comprehensive metabolic health system, Trilivy. The company's holistic approach integrates science-backed plans and nutritionally optimized products, personal 1:1 coaching from independent coaches, a supportive community, and behavioral science support to develop healthy habits. Medifast's proprietary Metabolic Synchronization science targets metabolic dysfunction through a system focused on fat loss, lean mass preservation, and long-term health. Trilivy's three-part metabolic health system is designed to help people reset their metabolism, refine their health, and renew their lives. The company distributes its products through a network of independent active earning coaches who acquire and support clients. With more than 45 years of clinical heritage, Medifast serves the growing market for metabolic health solutions at a time when GLP-1 weight loss medications are reshaping the competitive landscape. Updated
Management now guides to a return to profitability in the fourth quarter, with EPS of $0.00 to $0.25, after a quarterly loss that beat expectations. Revenue per active earning coach rose 54.1%, the fourth straight quarterly gain, even as the coach count fell under GLP-1 pressure.
With a market rotation underway, where should investors seeking opportunities in health care be looking? Analysts have high expectations for Alphatec.
The inflationary environment over the past few years has constricted consumer buying power, resulting in supplementary income requirements by many. For those who cannot augment their paychecks with additional part-time jobs but…
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital appreciation potential are essential for…
Since 1926, dividends have contributed approximately 32% of the total return for the S&P 500, while capital appreciations have contributed 68%. Therefore, sustainable dividend income and capital appreciation potential are essential for…
Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time. In…
Investors love dividend stocks because they provide dependable income and give investors a great opportunity for solid total return. Total return includes interest, capital gains, dividends, and distributions realized over time. In…
Monday's top analyst upgrades and downgrades included Altice USA, Arista Networks, Block, Cardinal Health, ConocoPhillips, Datadog, GoodRx, Monster Beverage, PepsiCo, Spirit AeroSystems, Twilio and WeWork.
Medifast, Inc. (NYSE: MED) is a metabolic health and wellness company operating through its science-backed comprehensive metabolic health system, Trilivy.
The Wall Street consensus 12-month price target for MED is $12.00.
